Oncocardiology: Far beyond the cardiotoxicity
- 29 November 2022
- journal article
- Published by Heighten Science Publications Corporation in Journal of Cardiology and Cardiovascular Medicine
- Vol. 7 (3), 098-099
- https://doi.org/10.29328/journal.jccm.1001141
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)European Heart Journal, 2022
- Atrial fibrillation in cancer patients who develop strokeCardio-Oncology, 2022
- Cardiovascular Inflammaging: Mechanisms and Translational AspectsCells, 2022
- DNA damage response in vascular endothelial senescence: Implication for radiation-induced cardiovascular diseasesJournal of Radiation Research, 2021
- Preheart failure comorbidities and impact on prognosis in heart failure patients: a nationwide studyJournal of Internal Medicine, 2020
- Association with outcomes and response to treatment of trimethylamine N‐oxide in heart failure: results from BIOSTAT‐CHFEuropean Journal of Heart Failure, 2018
- Oncocardiology—Past, Present, and FutureJAMA Cardiology, 2016
- Cardiovascular Status of Childhood Cancer Survivors Exposed and Unexposed to Cardiotoxic TherapyJournal of Clinical Oncology, 2012